Novartis announced top line results of its ianalumab (VAY736;B cell inhibitor) in primary Sjögren’s dz. 2 RCTs,… Read More
RheumNow
2025 BSR Recommendations for ANCA-associated Vasculitis The BSR and BHPR have published a guideline for the management… Read More
Rheums Speak – RA Treatment Survey RheumNow’s August 2025 “Live Vote” surveys will examine Rheumatologist impressio https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More
Aging Quiets Lupus UCSF researchers have found that epigentic changes in interferon genes over time may lead… Read More
NEW EULAR POSTER: Real-world treatment patterns across the first 12 months of first-line advanced therapy in patients… Read More
NEW EULAR POSTER: Real-world impact of second-line treatment choice in patients with PsA! 🔎View the effectiveness o… Read More
“What you do makes a difference, and you have to decide what kind of difference you want… Read More